GL1X · GenesisL1 explorer

Research workbench

Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with P1-P6 substrate variant (L449F)

Analyse Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QJ6
Type
protein
Length
414 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease; P1-P6 peptide
EC
3.4.23.16
UniProt
P03369
Ligands
SO4
Pockets
3 · best druggability 0.51

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DProtease (EC 3.4.23.16)protein997% helix, 55% strandP03369
EP1-P6 peptideprotein100% helix, 30% strand—
FP1-P6 peptideprotein80% helix, 50% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A, B, E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11800.510.7720empty
2750.500.8521empty
31720.430.7428empty

Interfaces

11 interfaces between chains.

  • C–D · 1818 Ų buried · 38 hydrogen bonds · protein-protein
  • A–B · 1780 Ų buried · 38 hydrogen bonds · protein-protein
  • B–E · 608 Ų buried · 14 hydrogen bonds · protein-protein
  • D–F · 540 Ų buried · 11 hydrogen bonds · protein-protein
  • C–F · 528 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4QJ6 · Crystal structure of inactive HIV-1 protease variant (I50V/A71V) in complex with p1-p6… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.